Oral Micronized Progesterone Cost in Ohio 2026

What Does Oral Micronized Progesterone Cost in Ohio Right Now?

Ohio women paying cash for oral micronized progesterone in 2026 pay an average of $45 per month at retail pharmacies, according to current pricing aggregator data. That is roughly 75 percent below Prometrium's $180 manufacturer list price, primarily because several FDA-approved generics have entered the market and competition among Ohio's major pharmacy chains has driven prices down sharply.

Brand vs. Generic Pricing at Ohio Pharmacies

Prometrium (brand, manufactured under Solvay Pharmaceuticals' legacy license) lists at $180 per month for a 30-day supply of 200 mg capsules. Generic micronized progesterone, bioequivalent by FDA standards, is dispensed by chains including CVS, Walgreens, Kroger Pharmacy, and Marc's at prices typically between $38 and $55 per month depending on capsule strength and the individual store's negotiated acquisition cost.

A 100 mg nightly dose (continuous combined regimen) tends to run slightly cheaper per unit than 200 mg cyclic dosing, simply because the lower-strength capsules have broader generic competition. Ask your pharmacist to run both strengths through their pricing system before you fill.

Compounded Progesterone at Ohio 503A Pharmacies

Ohio-licensed 503A compounding pharmacies can prepare oral micronized progesterone for individual patients under a valid prescription. Compounded versions average approximately $25 per month, making them the lowest cash-pay option available. Compounding is appropriate when a patient needs a non-standard dose, an oil-based capsule formulation, or an excipient-free preparation for documented allergy.

The FDA's guidance on pharmacy compounding distinguishes 503A (patient-specific, physician-supervised) from 503B (outsourcing facilities for bulk supply). For individual Ohio patients, the relevant pathway is 503A. FDA 503A compounding framework applies directly.

Is Oral Micronized Progesterone Legal to Prescribe and Compound in Ohio?

Yes on both counts. Ohio law permits licensed prescribers to order FDA-approved oral micronized progesterone (Prometrium or generic) for any medically appropriate indication, and Ohio Board of Pharmacy-licensed 503A compounding pharmacies may prepare patient-specific compounded progesterone capsules. Neither activity requires special DEA scheduling because progesterone is not a controlled substance under federal or Ohio law.

Ohio Board of Pharmacy and 503A Compliance

Ohio 503A pharmacies must comply with USP standards and the Ohio Board of Pharmacy's compounding rules (Ohio Administrative Code Chapter 4729-16). Patients should verify that a compounding pharmacy holds an active Ohio license before filling. The Board's public license search is available at pharmacy.ohio.gov.

Telehealth Prescribing Rules in Ohio

Ohio telehealth prescribing rules, updated under HB 122 (2023), allow licensed Ohio prescribers to issue a prescription for oral micronized progesterone after a synchronous audio-video visit without a prior in-person exam, provided the clinical encounter meets standard-of-care documentation requirements. This means a board-certified clinician on a telehealth platform can legally prescribe Prometrium or a generic to an Ohio patient during a video call.

Telehealth platforms operating in Ohio must hold or employ prescribers with active Ohio medical or advanced practice nursing licenses. Prescriptions issued cross-state (e.g., a physician licensed only in Indiana prescribing to an Ohio patient) are not valid under Ohio law unless that physician also holds an Ohio license.

Does Ohio Medicaid Cover Oral Micronized Progesterone?

Ohio Medicaid does not cover oral micronized progesterone for the hormone therapy (endometrial protection) indication. The Ohio Department of Medicaid Preferred Drug List excludes progestins used solely for menopausal HRT. Coverage is available for type 2 diabetes-related indications only, which is not the typical use case for most women seeking progesterone as part of hormone therapy.

What Medicaid Does and Does Not Cover

| Indication | Ohio Medicaid Coverage | |---|---| | Menopausal HRT / endometrial protection | Not covered | | Threatened miscarriage (OB use) | May be covered (case-by-case) | | Luteal phase support (ART cycles) | May be covered under some managed care plans | | Type 2 diabetes co-indication | Covered per PDL |

Ohio Medicaid recipients who need progesterone for HRT must either pay cash, use a manufacturer savings program, or request a Medicaid exception through their managed care organization. Exceptions are granted rarely and require documented medical necessity with a prescriber letter.

Managed Care Plans Within Ohio Medicaid

Ohio Medicaid operates through five managed care organizations: CareSource, Buckeye Health Plan, Molina Healthcare, UnitedHealthcare Community Plan, and Humana. Each MCO maintains its own formulary. While the state PDL excludes HRT progesterone, individual MCO contracts sometimes add coverage. Calling the plan's pharmacy benefits line with the NDC for your specific progesterone product is the fastest way to confirm current coverage.

Which Private Insurance Plans Cover Oral Micronized Progesterone in Ohio?

Most commercial insurance plans in Ohio cover FDA-approved oral micronized progesterone, usually on Tier 2 or Tier 3. The PEPI Trial (JAMA 1995, N=875) established that micronized progesterone protects the endometrium from unopposed estrogen-induced hyperplasia, and that clinical evidence base is why payers categorize it as medically necessary rather than elective. PEPI Trial, JAMA 1995

Tier Placement and Prior Authorization

Prometrium brand typically lands on Tier 3 (preferred brand), generating a copay of $40 to $70 per month depending on plan design. Generic micronized progesterone sits on Tier 1 or Tier 2 at most Ohio commercial plans, with copays of $5 to $25 per month.

Prior authorization (PA) is required by some plans, particularly for women under 45 or for continuous (as opposed to cyclic) dosing. A PA request should reference the FDA-approved labeling for Prometrium and, if denied, can be appealed using the PEPI trial data showing that micronized progesterone at 200 mg cyclic produced zero cases of endometrial hyperplasia vs. 28 percent for placebo over 3 years [1].

ACA Marketplace Plans in Ohio

Under ACA rules, marketplace plans sold through HealthCare.gov cover prescription drugs. Ohio marketplace plans (Anthem, Medical Mutual, Oscar, Molina) generally list generic progesterone on Tier 1 or Tier 2 formularies. Out-of-pocket costs after deductible are typically $0 to $30 per month. Check the Summary of Benefits and Coverage (SBC) document for your specific plan at HealthCare.gov before enrollment.

Medicare Part D

Medicare Part D covers oral micronized progesterone when prescribed for an approved indication. Under standard 2026 Part D benefit design (post-IRA reform), the $2,000 annual out-of-pocket cap limits total annual spending regardless of tier. Most Part D plans place generic progesterone on Tier 1 to Tier 2, yielding copays of $5 to $15 per month before reaching the catastrophic threshold.

How to Get the Lowest Possible Price in Ohio

The cheapest route to oral micronized progesterone in Ohio depends on your insurance status. The decision tree below structures the options from lowest to highest net cost.

Decision Framework: Lowest Net Cost by Insurance Status

Uninsured or cash-pay patients:

1. Request generic micronized progesterone (not brand Prometrium) at any Ohio pharmacy.
2. Use GoodRx, RxSaver, or Blink Health to compare real-time prices at your ZIP code. Prices at Costco Pharmacy in Columbus have recently ranged as low as $18 per month for a 30-day supply of 100 mg generics.
3. If a non-standard dose or excipient-free formulation is medically appropriate, ask your prescriber to send the Rx to a licensed Ohio 503A compounding pharmacy at approximately $25 per month.
4. Apply for the manufacturer's patient assistance program (see below).

Insured patients with high copays:

1. Confirm your plan's formulary tier for the specific NDC your pharmacy dispenses.
2. Request a therapeutic substitution appeal if brand Prometrium is dispensed but the generic is on a lower tier.
3. Apply the Prometrium savings card (see below) to reduce brand copays.
4. Ask your prescriber to document medical necessity if a PA is pending.

Prometrium Manufacturer Savings Card

Solvay's legacy license holder offers a savings card that reduces brand Prometrium copays to as low as $25 per fill for commercially insured patients. The card does not apply to Medicaid, Medicare Part D, or other federal programs. Enrollment is online and approval is typically immediate. The card is accepted at most Ohio retail pharmacies but not at all independent compounding pharmacies, so confirm acceptance before presenting.

GoodRx and Third-Party Discount Programs

GoodRx coupons for generic micronized progesterone 200 mg (30 capsules) currently show prices between $22 and $55 at Ohio pharmacies depending on location and chain. Cleveland-area Costco Pharmacy and Columbus-area Kroger Pharmacy have appeared at the lower end of that range in recent pricing pulls. Using a GoodRx coupon means you pay the discount price instead of your insurance copay, so compare both before swiping your pharmacy benefits card.

Do not present both a GoodRx coupon and an insurance card for the same prescription. Pharmacies can process only one discount per transaction. Choose whichever is cheaper for that fill.

Clinical Background: Why Oral Micronized Progesterone Is Prescribed

Oral micronized progesterone is the bioidentical form of endogenous progesterone, and it received FDA approval as Prometrium for use in postmenopausal women receiving conjugated estrogen to reduce the risk of endometrial hyperplasia. The FDA-approved prescribing label specifies 200 mg nightly for 12 days per month (cyclic) or 100 mg nightly continuously in women who have not had a hysterectomy. Prometrium FDA label, accessdata.fda.gov

What the PEPI Trial Established

The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial enrolled 875 healthy postmenopausal women and randomized them to placebo, unopposed conjugated estrogen, or estrogen combined with various progestin regimens, including micronized progesterone 200 mg cyclic. After 3 years, endometrial hyperplasia occurred in 28 percent of the unopposed estrogen group but in 0 percent of the micronized progesterone cyclic group (P<0.001). PEPI Trial, JAMA 1995 That zero-hyperplasia finding is the cornerstone of current guideline support for oral micronized progesterone as the preferred progestogen in HRT.

Menopause Society (NAMS) Guideline Position

The Menopause Society (formerly NAMS) 2022 Hormone Therapy Position Statement states: "Micronized progesterone is preferred over synthetic progestins when a progestogen is needed, because observational data suggest a more favorable cardiovascular and breast risk profile." Menopause Society 2022 Position Statement That language directly supports the medical necessity argument used in insurance PA appeals.

Cardiovascular and Breast Safety Signals

The E3N French cohort (N=80,377 women-years of follow-up) found that transdermal estrogen combined with micronized progesterone was not associated with an increased breast cancer risk, in contrast to synthetic progestins, which carried a relative risk of approximately 1.4. While observational data cannot establish causation, the signal has influenced prescriber preference and formulary decision-making. E3N cohort, Breast Cancer Res Treat 2008

Dosing Schedules and Their Effect on Monthly Cost

Dosing schedule affects the quantity dispensed per month and therefore the cash-pay price. Ohio pharmacies calculate 30-day supply cost differently depending on whether the Rx is written for cyclic or continuous use.

Continuous Regimen

Continuous dosing: 100 mg oral capsule nightly, 30 capsules per month. This is the most common regimen for women on continuous combined HRT (typically postmenopausal women who prefer no withdrawal bleed). At $45 per month average, this equals $1.50 per capsule.

Cyclic Regimen

Cyclic dosing: 200 mg oral capsule nightly for days 1 to 12 of each calendar month (12 capsules per cycle). A 30-day prescription written for this regimen will often be dispensed as a 12-count per cycle, and your insurer may require a quantity limit override to fill 12 capsules rather than 30. Cash-pay cost for 12 capsules of 200 mg generic runs approximately $12 to $20 per cycle at Ohio retail pharmacies, making this the least expensive per-cycle option for cash-pay patients.

Special Populations and Access Considerations in Ohio

Perimenopausal Women Under 50

Ohio prescribers can prescribe oral micronized progesterone to perimenopausal women under age 50, though insurance prior authorization is more frequently required in this age group. The clinical rationale (anovulatory cycles producing unopposed estrogen) is well documented, and a prescriber letter citing irregular cycle data strengthens the PA request.

Women With Peanut Allergy

Prometrium capsules contain peanut oil as an excipient. Women with a documented peanut allergy should not use the brand or most generic versions. A licensed Ohio 503A compounding pharmacy can prepare a peanut oil-free micronized progesterone capsule using an alternative carrier, typically olive oil or sunflower oil. The cost is roughly the same as other compounded formulations, approximately $25 per month, and a compounded formulation requires a prescriber note documenting the allergy.

Transgender Men and Non-Binary Patients

Ohio prescribers may prescribe oral micronized progesterone off-label to transgender men and non-binary patients for a range of indications. Insurance coverage for this population varies by plan. Many Ohio commercial plans cover it under the same formulary tier as for cisgender women; others require a PA citing the Endocrine Society's Transgender Care Clinical Practice Guidelines. Endocrine Society Transgender Guidelines

How to Get a Prescription for Oral Micronized Progesterone in Ohio

Ohio patients can obtain a prescription through three pathways: an in-person visit with a gynecologist, OB/GYN, or primary care physician; a telehealth visit with an Ohio-licensed provider on a digital health platform; or a visit to an Ohio women's health clinic or federally qualified health center (FQHC).

Telehealth is the fastest pathway for most working Ohio women. After a synchronous video visit, most platforms send the prescription electronically to any Ohio pharmacy the patient selects. Most Ohio-licensed telehealth prescribers can complete the visit and send the prescription within 24 to 48 hours. Ask whether the platform uses an Ohio-licensed prescriber before booking, not after.

For those using HealthRX, a board-certified clinician will review hormone history, current symptoms, and any prior lab results (FSH, estradiol, LH) at the initial visit. Most new patients receive an Rx decision within the same appointment. HealthRX operates under Ohio telehealth law and accepts most major Ohio commercial insurance plans.

The standard starting dose for continuous combined HRT is 100 mg of oral micronized progesterone nightly taken at bedtime. The sedating effect of progesterone (mediated via GABA-A receptor modulation) is a known and, for many patients with sleep complaints, welcome side effect at this dose.